vialaudit
The Roundup
orforglipron · maryland

Is Orforglipron legal in Maryland?

status · caveats apply
FDA-approved oral GLP-1 (Foundayo, April 1, 2026) under National Priority Voucher Program; first oral small-molecule GLP-1. No state-level peptide restrictions beyond federal law in Maryland.

category: investigational · last verified May 13, 2026

§ 01

Quick answer

FDA-approved oral GLP-1 (Foundayo, April 1, 2026) under National Priority Voucher Program; first oral small-molecule GLP-1. No state-level peptide restrictions beyond federal law in Maryland.
§ 02

Full status breakdown

Federal status

FDA approval
investigational · brand: Foundayo · approved Apr 1, 2026
Indications: chronic weight management in adults with obesity or overweight with weight-related comorbidity
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Approved drug; not a §503A candidate.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: As an approved drug, 'research peptide' sales would be unapproved diversion + FDCA violation. No warning letters yet (new approval).
Personal possession: Not federally criminalized; controlled by prescription via LillyDirect.

Maryland — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2 · both
GLP-1 receptor agonist class effect under S2.
USADA
NCAA
unknown

What we couldn’t verify

§ 03

Also known as

Orforglipron is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • LY3502970
  • Foundayo
  • Eli Lilly oral GLP-1
  • OGP
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch